Company / SG&A per Share
Apogee Therapeutics, Inc. SG&A per Share History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.89
FY2024
5-year range
$0.89 / $1.19
FY2022-FY2024
Trend
-9.7%
vs FY2023
Sector context
#132 of 210
Health Care
What the data says
At $0.89, Apogee Therapeutics, Inc.'s sg&a per share ranks #79 of 210 in the Health Care sector. Improved from $1.19 to $0.89 over the past 2 years.
Based on SEC 10-K filings.
0.89 in FY2024.
Improved from $1.19 to $0.89 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#79 of 210 in Health CareTop 37% of 210This company $0.89 Sector average $40.75
▼
-97.8% below sector average
Key checks
Key Insights
- In FY2024, sg&a per share decreased 9.7% year-over-year.
- Ranks #132 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.89 | -9.7% |
| FY2023 | $0.98 | -17.7% |
| FY2022 | $1.19 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026